GSK is a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. We are the largest UK pharmaceutical company and the biggest private investor in R&D in the UK. Our products are used by millions of people around the world, helping them to do more, feel better and live longer. There are three primary areas of our business; pharmaceuticals, vaccines and consumer healthcare. Through our consumer healthcare business, we market a range of products based on scientific innovation covering oral health, wellness, skin health and nutrition. Our consumer healthcare brands Lucozade and Macleans are Royal Warrant Holders.

Celebrating innovation
The Coronation Festival is a celebration of British innovation and as a British company we are proud of our heritage in developing and supplying healthcare. The Coronation Festival is an excellent opportunity for us to celebrate our achievements in the pharmaceutical and consumer healthcare industries over the last 60 years and the contributions we make to Britain's economy by providing employment in manufacturing and R&D, exporting critical healthcare products, collaborating with universities on leading edge research, and inspiring the next generation of scientists.

Our partnerships
Collaborating with other companies, organisations and academics is a fundamental part of our business strategy. We are committed to working with our partners to facilitate the rapid discovery and development of new medicines, pioneer advances in vaccines against preventable diseases to help reduce the impact of disease on the world's population, and share expertise to encourage innovation and stimulate entrepreneurship.

Improving healthcare globally and locally
As a leading global healthcare company we have been able to help improve healthcare systems in some of the poorest countries across the world. We have a number of global Corporate Responsibility programmes that we have used to achieve this. We are one of the few pharmaceutical companies researching both medicines and vaccines for the World Health Organisation's three priority diseases; HIV/AIDS, tuberculosis and malaria. Investing in our people and communities also helps us ensure the long-term sustainability of our business. Our employment practices are designed to help us create the right workplace culture in which all employees feel valued, respected, empowered and inspired. We also want the many communities we work in to prosper as our business grows. Our community investment strengthens our business by supporting the local economies where we operate, helping us build relationships based on mutual understanding and also boosting employee morale.

GlaxoSmithKline is proud of its partnership with the Coronation Festival at Buckingham Palace 11-14 July 2013.